Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Account Payables: 2017-2024

Historic Change in Account Payables for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $3.1 million.

  • Bicycle Therapeutics' Change in Account Payables fell 309.20% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 295.50%. This contributed to the annual value of $3.1 million for FY2024, which is 61.32% down from last year.
  • Bicycle Therapeutics' Change in Account Payables amounted to $3.1 million in FY2024, which was down 61.32% from $8.0 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Change in Account Payables peaked at $8.0 million during FY2023, and registered a low of -$663,000 during FY2020.
  • Moreover, its 3-year median value for Change in Account Payables was $3.1 million (2024), whereas its average is $4.6 million.
  • Its Change in Account Payables has fluctuated over the past 5 years, first tumbled by 401.36% in 2020, then surged by 280.39% in 2021.
  • Over the past 5 years, Bicycle Therapeutics' Change in Account Payables (Yearly) stood at -$663,000 in 2020, then surged by 280.39% to $1.2 million in 2021, then soared by 114.13% to $2.6 million in 2022, then soared by 212.46% to $8.0 million in 2023, then slumped by 61.32% to $3.1 million in 2024.